PTGX Competitors & Alternatives
Compare Protagonist Therapeutics Inc with similar stocks in the same industry
Biotechnology
PTGX
Main Stock$138.08
Tradestie Score
66
Market Cap
$3.98B
P/E Ratio
134.0
Revenue Growth
37.5%
Analyst Upside
+29.1%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BMRN
BioMarin Pharmaceuticals Inc
|
$55.52
|
$10.53B | 152.5 | 72 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$44.27
|
$10.49B | - | 69 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$67.74
|
$10.22B | - | 70 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$457.96
|
$10.01B | - | 59 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.64
|
$9.33B | 62.6 | 59 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$116.28
|
$8.88B | 258.8 | 55 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$124.83
|
$8.77B | 35.8 | 40 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$194.28
|
$8.57B | - | 58 | Compare |
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$32.35
|
$8.53B | 18.4 | 46 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$211.97
|
$8.30B | 14.7 | 56 | Compare |
More PTGX Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry